Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 16 studies | 31% ± 10% | |
| lung | 15 studies | 28% ± 12% | |
| intestine | 8 studies | 21% ± 8% | |
| eye | 5 studies | 29% ± 13% | |
| lymph node | 5 studies | 23% ± 5% | |
| kidney | 4 studies | 23% ± 4% | |
| bone marrow | 4 studies | 23% ± 8% | |
| uterus | 4 studies | 34% ± 15% | |
| brain | 4 studies | 24% ± 3% | |
| pancreas | 3 studies | 34% ± 6% | |
| liver | 3 studies | 37% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6273.56 | 1445 / 1445 | 100% | 58.98 | 183 / 183 |
| lung | 100% | 6040.81 | 578 / 578 | 100% | 69.11 | 1155 / 1155 |
| ovary | 100% | 6448.89 | 180 / 180 | 100% | 62.38 | 430 / 430 |
| prostate | 100% | 5272.68 | 245 / 245 | 100% | 87.39 | 502 / 502 |
| stomach | 100% | 4408.74 | 359 / 359 | 100% | 63.97 | 286 / 286 |
| thymus | 100% | 6304.56 | 653 / 653 | 100% | 115.97 | 605 / 605 |
| uterus | 100% | 6618.12 | 170 / 170 | 100% | 97.43 | 459 / 459 |
| intestine | 100% | 6428.98 | 966 / 966 | 100% | 71.44 | 526 / 527 |
| skin | 100% | 6396.33 | 1809 / 1809 | 100% | 87.87 | 471 / 472 |
| kidney | 100% | 4353.91 | 89 / 89 | 100% | 84.33 | 899 / 901 |
| brain | 100% | 4794.64 | 2636 / 2642 | 100% | 93.81 | 705 / 705 |
| breast | 100% | 6310.19 | 459 / 459 | 100% | 99.47 | 1115 / 1118 |
| bladder | 100% | 6130.33 | 21 / 21 | 100% | 74.71 | 502 / 504 |
| adrenal gland | 100% | 5581.31 | 258 / 258 | 100% | 81.00 | 229 / 230 |
| liver | 100% | 2527.93 | 225 / 226 | 100% | 61.64 | 406 / 406 |
| pancreas | 98% | 2478.44 | 320 / 328 | 100% | 78.94 | 178 / 178 |
| adipose | 100% | 6160.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7124.37 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 73.05 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 119.98 | 29 / 29 |
| muscle | 100% | 6917.70 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6427.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 95.41 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.15 | 1 / 1 |
| peripheral blood | 99% | 6014.95 | 923 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 3991.12 | 846 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0034501 | Biological process | protein localization to kinetochore |
| GO_0007094 | Biological process | mitotic spindle assembly checkpoint signaling |
| GO_0000278 | Biological process | mitotic cell cycle |
| GO_0000228 | Cellular component | nuclear chromosome |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0097431 | Cellular component | mitotic spindle pole |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | IK |
| Protein name | Protein Red (Cytokine IK) (IK factor) (Protein RER) IK cytokine IK cytokine, down-regulator of HLA II |
| Synonyms | RED RER |
| Description | FUNCTION: Involved in pre-mRNA splicing as a component of the spliceosome . Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable). Required for normal mitotic cell cycle progression . Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint . Required for normal accumulation of SMU1 . .; FUNCTION: (Microbial infection) Required, together with SMU1, for normal splicing of influenza A virus NS1 pre-mRNA, which is required for the production of the exportin NS2 and for the production of influenza A virus particles. Not required for the production of VSV virus particles. . |
| Accessions | ENST00000513256.5 ENST00000417647.7 ENST00000508301.5 ENST00000502899.2 D6RAY9 Q13123 E7EQZ7 D6RCQ4 Q95HA6 ENST00000507593.5 D6REL4 D6RAH1 ENST00000503332.5 |